Farbe Firma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Farbe Firma Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $229.6K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Farbe Firma Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $229.6K Trade | TransData Nexus

Product Portfolio — Top 3 by Export Value

Farbe Firma Private Limited exports 3 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Diazepam	CNS & Psychiatric	$134.6K	13	1.8%	8
2	Fentanyl	Analgesics & Antipyretics	$56.3K	9	1.5%	9
3	Morphine	Analgesics & Antipyretics	$38.7K	8	0.2%	10

Farbe Firma Private Limited exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $229.6K. The top category is CNS & Psychiatric (58.6% of portfolio), followed by Analgesics & Antipyretics (41.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Farbe Firma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Farbe Firma Private Limited is a pharmaceutical company based in Ankleshwar, Gujarat, India, specializing in the manufacturing of sterile injectable formulations. Established on June 3, 2021, the company operates under the Corporate Identification Number (CIN) U24100GJ2021PTC123062. The authorized and paid-up capital of the company is ₹10.00 crore each. As of March 31, 2024, Farbe Firma employed 143 professionals. The company's registered office is located at Plot No. 1508, B/H Arail Lab GIDC, Ankleshwar, Gujarat, 393002. Farbe Firma's website is www.farbefirma.org.

2Manufacturing Facilities

Farbe Firma's manufacturing facility is situated in Ankleshwar, Gujarat, India. The plant specializes in the production of sterile injectable formulations, including ampoules, liquid vials, lyophilized vials, and emulsions. The facility is WHO-GMP certified, ensuring adherence to international quality standards. The plant is equipped with advanced, fully automated sterile production lines capable of high-capacity output to meet global pharmaceutical demand.

3Key Leadership

Farbe Firma Private Limited is led by Directors Maulikkumar Jaysukhbhai Sudani and Jignasu Jaysukhbhai Sudani, both appointed on June 3, 2021. Maulikkumar Sudani serves as the Founder, while Jignasu Sudani is the Co-Founder. Their leadership has been instrumental in the company's growth and expansion into the production of sterile injectable formulations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Farbe Firma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Farbe Firma Private Limited has achieved regulatory approvals in over 25 countries, including India, the Philippines, Myanmar, Iraq, Yemen, Uzbekistan, Sri Lanka, Mongolia, Turkmenistan, Azerbaijan, Comoros, Papua New Guinea, Nigeria, Ethiopia, DR Congo, Kenya, Uganda, Angola, Mozambique, Ghana, Malawi, Rwanda, Cameroon, Peru, Venezuela, and Bolivia. This extensive regulatory compliance underscores the company's commitment to meeting international standards and expanding its global footprint.

2Emerging Markets

Farbe Firma's strategic focus on emerging markets has led to approvals in several countries across Africa, Asia, and Latin America. The company's WHO-GMP certification facilitates access to these markets, enabling it to supply high-quality sterile injectables to regions with growing healthcare needs.

3Geographic Strategy

Farbe Firma's geographic strategy emphasizes diversification by securing approvals in a wide array of countries across different continents. This approach mitigates concentration risk and positions the company to leverage growth opportunities in various regions. The strategic direction focuses on expanding its presence in both regulated and emerging markets, aligning with global healthcare demands.

Farbe Firma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of the latest available data, specific details regarding FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history for Farbe Firma Private Limited are not publicly disclosed. The company's focus on WHO-GMP certification suggests a commitment to meeting international quality standards, which may facilitate future FDA approvals.

2WHO & EU GMP

Farbe Firma's manufacturing facility is WHO-GMP certified, ensuring compliance with international quality standards for sterile injectable formulations. While specific EU GMP certifications are not detailed, the company's adherence to WHO-GMP standards positions it favorably for potential EU market access.

3CDSCO & Indian Regulatory

Farbe Firma Private Limited holds a state FDA manufacturing license, indicating compliance with the Drugs & Cosmetics Act of India. The company's WHO-GMP certification further demonstrates its commitment to meeting Indian regulatory standards for pharmaceutical manufacturing.

Farbe Firma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Farbe Firma Private Limited operates in the competitive market of sterile injectable formulations, facing competition from both domestic and international manufacturers. The company's WHO-GMP certification and extensive regulatory approvals across multiple countries enhance its competitive position. However, specific market share comparisons and head-to-head analyses with competitors are not publicly available.

2Key Differentiators

Farbe Firma's key differentiators include its exclusive focus on sterile injectable formulations, WHO-GMP certification, and a robust global export network spanning over 25 countries. These factors contribute to its reputation as a trusted Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) partner.

3Strategic Position

Farbe Firma Private Limited's strategic direction centers on the production of sterile injectable formulations, including ampoules, liquid vials, lyophilized vials, and emulsions. The company's WHO-GMP certification and extensive regulatory approvals across multiple countries underscore its commitment to quality and global expansion. Future outlooks suggest continued growth in both regulated and emerging markets, leveraging its manufacturing capabilities and strategic partnerships.

Buyer Due Diligence Brief — Evaluating Farbe Firma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Farbe Firma Private Limited demonstrates a strong track record in pharmaceutical manufacturing, with a focus on sterile injectables. The company's export volume and consistency are supported by its WHO-GMP certification and approvals in over 25 countries. Reliability indicators include adherence to international quality standards and a commitment to timely production.

2Certifications to Verify

Importers should verify the following certifications when considering Farbe Firma Private Limited as a supplier:

WHO-GMP Certification: Ensures compliance with international quality standards for pharmaceutical manufacturing.

State FDA Manufacturing License: Demonstrates compliance with Indian regulatory standards for pharmaceutical manufacturing.

Verification can be conducted by requesting copies of the certificates directly from the company or by consulting the respective regulatory bodies.

Due Diligence Checklist

Frequently Asked Questions — Farbe Firma Private Limited

How many pharmaceutical products does Farbe Firma Private Limited export from India?

Farbe Firma Private Limited exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Diazepam ($134.6K), Fentanyl ($56.3K), Morphine ($38.7K). Total export value is $229.6K.

What is Farbe Firma Private Limited's total pharmaceutical export value?

Farbe Firma Private Limited's total pharmaceutical export value is $229.6K, based on 30 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Farbe Firma Private Limited cover?

Farbe Firma Private Limited exports across 2 therapeutic categories. The largest are CNS & Psychiatric (58.6%, 1 products), Analgesics & Antipyretics (41.4%, 2 products).

Get Full Farbe Firma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Farbe Firma Private Limited

Farbe Firma Private Limited — Export Portfolio & Destination Treemap

Who is Farbe Firma Private Limited? — Company Overview & Market Position

What Does Farbe Firma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

Farbe Firma Private Limited Therapeutic Categories — 2 Specializations